דביגטרן אס.קיי 75 מג  Izrael - hebrajski - Ministry of Health

דביגטרן אס.קיי 75 מג

k.s.kim international ltd - dabigatran etexilate - קפסולות - dabigatran etexilate 75 mg - dabigatran etexilate

ריספרידון טבע 25 מג Izrael - hebrajski - Ministry of Health

ריספרידון טבע 25 מג

teva israel ltd - risperidone - אבקה וממס להכנת תרחיף בשחרור ממושך להזרקה - risperidone 25 mg/vial - risperidone

ריספרידון טבע 37.5 מג Izrael - hebrajski - Ministry of Health

ריספרידון טבע 37.5 מג

teva israel ltd - risperidone - אבקה וממס להכנת תרחיף בשחרור ממושך להזרקה - risperidone 37.5 mg/vial - risperidone

ריספרידון טבע 50 מג Izrael - hebrajski - Ministry of Health

ריספרידון טבע 50 מג

teva israel ltd - risperidone - אבקה וממס להכנת תרחיף בשחרור ממושך להזרקה - risperidone 50 mg/vial - risperidone

לנסופרזול טבע  30 מג Izrael - hebrajski - Ministry of Health

לנסופרזול טבע 30 מג

teva israel ltd - lansoprazole - קפסולות - lansoprazole 30 mg - lansoprazole - lansoprazole - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (gord) or duodenal ulcer. prevention of relapse in patients with gord or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short term treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome. treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.

מירנה Izrael - hebrajski - Ministry of Health

מירנה

bayer israel ltd - levonorgestrel - התקן תוך רחמי - levonorgestrel 52 mg - levonorgestrel and estrogen - levonorgestrel and estrogen - contraception and idiopathic menorrhagia. protection from endometrial hyperplasia during estrogen replacement therapy.

אביאנה Izrael - hebrajski - Ministry of Health

אביאנה

novo nordisk ltd., israel - estradiol as hemihydrate; norethisterone acetate - טבליות מצופות פילם - estradiol as hemihydrate 0.5 mg; norethisterone acetate 0.1 mg - estradiol, combinations - estradiol, combinations - eviana is indicated for women who have a uterus for the: treatment of moderate to severe vasomotor symptoms associated with menopause. prevention of postmenopausal osteoporosis. when prescribing solely for the prevention of postmenopausal osteoporosis therapy should only be considered for women at significant risk of osteoporosis and non-estrogen medications should be carefully considered.

אימובן Izrael - hebrajski - Ministry of Health

אימובן

sanofi israel ltd - zopiclone - טבליות מצופות פילם - zopiclone 7.5 mg - zopiclone - zopiclone - hypnotic when the disorder of insomnia is severe and disabling.

פוסרנול 500 מג טבליות לעיסה Izrael - hebrajski - Ministry of Health

פוסרנול 500 מג טבליות לעיסה

takeda israel ltd - lanthanum as carbonate hydrate - טבליות לעיסות - lanthanum as carbonate hydrate 500 mg - lanthanum carbonate - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd).fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.

פוסרנול     750 מג טבליות לעיסה Izrael - hebrajski - Ministry of Health

פוסרנול 750 מג טבליות לעיסה

takeda israel ltd - lanthanum as carbonate hydrate - טבליות לעיסות - lanthanum as carbonate hydrate 750 mg - lanthanum carbonate - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd).fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.